Flea octopamine receptor nucleic acid molecules, proteins and uses thereof
View Patent ↗The present invention relates to tick octopamine receptor nucleic acid molecules; to tick octopamine receptor proteins encoded by such nucleic acid molecules; to antibodies raised against such proteins; and to compounds that inhibit the activity of such proteins. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. The present invention also includes inhibitory compounds, particularly those that specifically inhibit tick octopamine receptor activity, as well as the use of such compounds to treat animals.
1. An isolated nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of:
(a) a nucleic acid sequence encoding a protein consisting of SEQ ID NO:4, SEQ ID NO:7 or SEQ ID NO:12; and
(b) a nucleic acid sequence fully complementary to the nucleic acid sequence of (a).
2. The isolated nucleic acid molecule of claim 1 , wherein said nucleic acid sequence is selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:11 and SEQ ID NO:13.
3. An isolated nucleic acid molecule consisting of a nucleic acid sequence selected from the group consisting of:
(a) a nucleic acid sequence encoding a protein consisting of SEQ ID NO:4, SEQ ID NO:7 or SEQ ID NO:12; and
(b) a nucleic acid sequence fully complementary to the nucleic acid sequence of (a).
4. The isolated nucleic acid molecule of claim 3 , wherein said nucleic acid sequence is selected from the group consisting of SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:11 and SEQ ID NO:13.
5. An isolated protein comprising an amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:7 and SEQ ID NO:12.
6. An isolated protein consisting of an amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:7 and SEQ ID NO:12.
7. A method to detect an inhibitor of octopamine receptor activity, said method comprising:
(a) contacting an isolated protein comprising SEQ ID NO:12 with octopamine and a putative inhibitory compound under conditions in which, in the absence of said compound, said octopamine will bind to said isolated protein; and
(b) determining if said octopamine binds to said isolated protein.